- Home
- LDWY vs NTBL Comparison
LDWY vs NTBL Comparison
Compare LDWY & NTBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- NTBL
- Stock Information
- Founded
- LDWY 1990
- NTBL 2000
- Country
- LDWY United States
- NTBL United States
- Employees
- LDWY N/A
- NTBL N/A
- Industry
- LDWY Advertising
- NTBL Biotechnology: Pharmaceutical Preparations
- Sector
- LDWY Consumer Discretionary
- NTBL Health Care
- Exchange
- LDWY Nasdaq
- NTBL Nasdaq
- Market Cap
- LDWY 6.7M
- NTBL 4.6M
- IPO Year
- LDWY 1991
- NTBL N/A
- Fundamental
- Price
- LDWY $3.42
- NTBL $0.25
- Analyst Decision
- LDWY
- NTBL Buy
- Analyst Count
- LDWY 0
- NTBL 2
- Target Price
- LDWY N/A
- NTBL $5.00
- AVG Volume (30 Days)
- LDWY 9.9K
- NTBL 8.1M
- Earning Date
- LDWY 11-11-2024
- NTBL 11-12-2024
- Dividend Yield
- LDWY N/A
- NTBL N/A
- EPS Growth
- LDWY N/A
- NTBL N/A
- EPS
- LDWY N/A
- NTBL N/A
- Revenue
- LDWY $24,813,000.00
- NTBL $313,000.00
- Revenue This Year
- LDWY N/A
- NTBL N/A
- Revenue Next Year
- LDWY N/A
- NTBL N/A
- P/E Ratio
- LDWY N/A
- NTBL N/A
- Revenue Growth
- LDWY N/A
- NTBL 3812.50
- 52 Week Low
- LDWY $3.02
- NTBL $0.22
- 52 Week High
- LDWY $6.88
- NTBL $4.24
- Technical
- Relative Strength Index (RSI)
- LDWY 46.04
- NTBL 35.14
- Support Level
- LDWY $3.34
- NTBL $0.28
- Resistance Level
- LDWY $3.66
- NTBL $0.37
- Average True Range (ATR)
- LDWY 0.20
- NTBL 0.06
- MACD
- LDWY 0.04
- NTBL -0.01
- Stochastic Oscillator
- LDWY 62.50
- NTBL 6.26
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About NTBL Notable Labs Ltd.
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.